Children’s immune systems react in a less vigorous way and they don’t get that sick. The immune system of adults sometimes overreacts to those viruses and that makes them sick.
Presently, in this global pandemic of COVID-19 infection there is very limited evidence that SARS-CoV-2 undergoes intrauterine or transplacental transmission from infected pregnant women to their fetuses.
Transmission however is likely in the postpartum period, limited case reports have identified Covid19 positive test in a newborn in London a few minutes after birth and another occuring 36 hours after birth in Wuhan. Skin to skin contact has also been advised against, but breastfeeding (expressed breast milk) has not been contraindicated.
A study published February 2020 in the Lancet, that aimed to ascertain if and when the SARS Cov 2 virus could be transmitted to neonates took samples of amniotic fluid, umbilical cord blood, breast milk and also the newborns' throat from nine, Covid-19 positive pregnant women admitted to a hospital in Wuhan, China between 36-39 weeks gestation where the outbreak first began. The women were all delivered via C-section. There findings demonstrated that None of those samples tested positive for the coronavirus. All the mothers and babies survived. Authors however concluded that larger studies are indicated.
Datonye Briggs do you have a reference for advising against skin to skin contact please? https://www.who.int/news-room/q-a-detail/q-a-on-covid-19-pregnancy-childbirth-and-breastfeeding encourages skin to skin contact.
Why COVID-19 appears to be less common and severe in children than in adults is unclear. Some considerations are a less intense immune response to the virus in children versus adults; cytokine release syndrome is thought to be important in the pathogenesis of severe COVID-19 infections. Another explanation is that viral interference in the respiratory tract of young children leads to a lower viral load in children. Finally, the receptor for the SARS-CoV-2 virus is the angiotensin-converting enzyme 2 receptors, which may be expressed differently in the respiratory tract of children compared to adults.
however the prevalence of covid 19 is very low in child ( under the age of 18 years ) but often mortality is in child with underlying medical disease or infants with under the age 1 year .